Nancy Miller-Rich

Throughout a career that began as a consumer products merchandiser through senior vice president in the pharmaceutical division of one of the world’s leading drug companies, Nancy has taken the initiative, built businesses, identified opportunities and demonstrated creativity and leadership.

From sales and marketing to business development, alliance management and digital transformation, Nancy has gained enterprise-wide perspective and expertise. She collaborates naturally and builds consensus at all levels, with an eye firmly locked on measurable business goals. That things grow around Nancy is no coincidence.

Since her most recent position in the Global Human Health division of Merck, where Nancy lead a number of critical initiatives, she has brought savvy insights to the boards of Intercept Pharmaceuticals, Alderya Therapeutics, Kadmon, 4D Molecular Therapeutics and TB Alliance

and a growing number of advisory clientele. Nancy has learned to disrupt business status quo and provoke innovation and growth through portfolio management, acquiring and divesting products and technologies, initiating and managing joint ventures, and investing in new drug platforms and initiatives.

Nancy has learned to disrupt business status quo and provoke innovation and growth through portfolio management, acquiring and divesting products and technologies, initiating and managing joint ventures, and investing in new drug platforms and initiatives.

Nancy is a lifelong devotee to fitness and giving back to her profession and communities. She is an active board member of a variety of civic, environmental, industry and corporate organizations and associations.